Conference abstract · 22 Jun 2015
Research articlePublished 15 Jun 2017
Roles and mechanisms of soybean isoflavones in androgen-independent transformation of prostate cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aims of this study were to investigate the impact of Soybean Isoflavones (SIFs) on the cellular oxidative stress levels in hormone-sensitive type (LNCap) and hormone-insensitive type (DU145) of prostate cancer, and to elucidate the main components and their roles in the transformation of Androgen Dependency (AD)/Androgen Independency (AI). The LNCap and DU145 cells were treated with different concentrations of SIFs monomer (including daidzin, genistin, daidzein, and genistein), and the activities of Superoxide Dismutase (SOD) and Malondialdehyde (MDA) were then measured. The content of Reactive Oxygen Species (ROS) in these two cells was also determined after treated with certain effective monomer. The contents of MDA in the two kinds of cells treated with genistein and daidzein were increased, but the contents of SOD were decreased in a concentration-dependent manner. There was no significant difference between daidzin and genistin. The content of MDA in the DU145 cells was higher than that in the LNCap cells under the same conditions, but the content of SOD was decreased, indicating that the oxidative stress level in DU-145 was higher than LNCap, and the ROS level in DU145 treated with effective component was significantly higher than that in LNCap. Genistein and daidzein in SIFs can affect the apoptosis and proliferation of prostate cancer cells through increasing their oxidative stress levels, thus inhibit the transformation of prostate cancer toward androgen-independent type.
Keywords
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 9 Nov 2022
Generally Speaking, Enzalutamide and Androgen Deprivation Therapy Improves Survival of Men with Metachronous Metastatic Hormone-Touchy Prostate Cancer
Mini review · 18 Mar 2022
Generally Speaking Survival of Men with Metachronous Metastatic Hormone-Touchy Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy
Conference abstract · 19 Jun 2013
Androgen receptor and its coactivators in prostate cancer
Conference abstract · 17 Nov 2015
The development of anti-androgens with a new mechanism of action for treatment of resistant prostate cancer
More from this journal
The newest in Biomedical Research.
Research article · 10 Dec 2025
Inhibitory Effects of Magnesium Hydroxide Nanoparticles on Osteoclast Differentiation via Suppression of RANKL-induced MAPK Signaling
Research article · 7 Oct 2025
Multimarker Approach to Assess Glycemic Control and Bone Metabolism in Type 2 Diabetes Mellitus with Potential for Enhanced Clinical Monitoring
Review article · 13 Aug 2025
Inventions in Telemedicine Shaping the Post-Pandemic Landscape: A Complete Review of Its Revolution and Influence in the USA
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomedical Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Li Xu”
- BylineArticles whose byline prints “Zhigang Cao”
- BylineArticles whose byline prints “Yemin Xue”
- BylineArticles whose byline prints “Shuli Zhao”
- BylineArticles whose byline prints “Kai Wang”
- BylineArticles whose byline prints “Chao Jiang”
- BylineArticles whose byline prints “Qichao Chen”

